Cancer Cell Signaling Pathways Targeted by Spice-Derived Nutraceuticals

REFERENCES

• Kamb , A , Wee , S and Lengauer , C . 2007 . Why is cancer drug discovery so difficult? . Nat Rev Drug Discov , 6 : 115 – 120 .
   PubMed Web of Science ®Google Scholar
• Knowles , J and Gromo , G . 2003 . A guide to drug discovery: target selection in drug discovery . Nat Rev Drug Discov , 2 : 63 – 69 .
   PubMed Web of Science ®Google Scholar
• Aggarwal , B B , Sethi , G , Baladandayuthapani , V , Krishnan , S and Shishodia , S . 2007 . Targeting cell signaling pathways for drug discovery: an old lock needs a new key . J Cell Biochem , 102 : 580 – 592 .
   PubMed Web of Science ®Google Scholar
• Fojo , T and Parkinson , D R . 2010 . Biologically targeted cancer therapy and marginal benefits: are we making too much of too little or are we achieving too little by giving too much? . Clin Cancer Res , 16 : 5972 – 5980 .
   PubMed Web of Science ®Google Scholar
• Aggarwal , B B , Danda , D , Gupta , S and Gehlot , P . 2009 . Models for prevention and treatment of cancer: problems vs. promises . Biochem Pharmacol , 78 : 1083 – 1094 .
   PubMed Web of Science ®Google Scholar
• Anand , P , Kunnumakkara , A B , Sundaram , C , Harikumar , K B Tharakan , S T . 2008 . Cancer is a preventable disease that requires major lifestyle changes . Pharm Res , 25 : 2097 – 2116 .
   PubMed Web of Science ®Google Scholar
• James , M A , Lee , J H and Klingelhutz , A J . 2006 . Human papillomavirus type 16 E6 activates NF-kappaB, induces cIAP-2 expression, and protects against apoptosis in a PDZ binding motif-dependent manner . J Virol , 80 : 5301 – 5307 .
   PubMed Web of Science ®Google Scholar
• DeLuca , C , Roulston , A , Koromilas , A , Wainberg , M A and Hiscott , J . 1996 . Chronic human immunodeficiency virus type 1 infection of myeloid cells disrupts the autoregulatory control of the NF-kappaB/Rel pathway via enhanced IkappaBalpha degradation . J Virol , 70 : 5183 – 5193 .
   PubMed Web of Science ®Google Scholar
• Aggarwal , B B , Vijayalekshmi , R V and Sung , B . 2009 . Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe . Clin Cancer Res , 15 : 425 – 430 .
   PubMed Web of Science ®Google Scholar
• 2007 . Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective , Washington, DC : American Institute for Cancer Research .
   Google Scholar
• Buiatti , E , Palli , D , Decarli , A , Amadori , D Avellini , C . 1989 . A case-control study of gastric cancer and diet in Italy . Int J Cancer , 44 : 611 – 616 .
   PubMed Web of Science ®Google Scholar
• Kaefer , C M and Milner , J A . 2008 . The role of herbs and spices in cancer prevention . J Nutr Biochem , 19 : 347 – 361 .
   PubMed Web of Science ®Google Scholar
• Chaturvedi , M M , Sung , B , Yadav , V R , Kannappan , R and Aggarwal , B B . 2011 . NF-kappaB addiction and its role in cancer: “one size does not fit all.” . Oncogene , 30 : 1615 – 1630 .
   PubMed Web of Science ®Google Scholar
• Aggarwal , B B , Van Kuiken , M E , Iyer , L H , Harikumar , K B and Sung , B . 2009 . Molecular targets of nutraceuticals derived from dietary spices: potential role in suppression of inflammation and tumorigenesis . Exp Biol Med (Maywood) , 234 : 825 – 849 .
   PubMed Web of Science ®Google Scholar
• Matthews , C P , Colburn , N H and Young , M R . 2007 . AP-1 a target for cancer prevention . Curr Cancer Drug Targets , 7 : 317 – 324 .
   PubMed Web of Science ®Google Scholar
• Aggarwal , B B , Sethi , G , Ahn , K S , Sandur , S K Pandey , M K . 2006 . Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution . Ann NY Acad Sci , 1091 : 151 – 169 .
   PubMed Web of Science ®Google Scholar
• Sen , R and Baltimore , D . 1986 . Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism . Cell , 47 : 921 – 928 .
   PubMed Web of Science ®Google Scholar
• Sethi , G , Sung , B and Aggarwal , B B . 2008 . Nuclear factor-kappaB activation: from bench to bedside . Exp Biol Med (Maywood) , 233 : 21 – 31 .
   PubMed Web of Science ®Google Scholar
• Singh , S and Aggarwal , B B . 1995 . Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected] . J Biol Chem , 270 : 24995 – 25000 .
   PubMed Web of Science ®Google Scholar
• Aggarwal , S , Ichikawa , H , Takada , Y , Sandur , S K Shishodia , S . 2006 . Curcumin (diferuloylmethane) downregulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation . Mol Pharmacol , 69 : 195 – 206 .
   PubMed Web of Science ®Google Scholar
• Chainy , G B , Manna , S K , Chaturvedi , M M and Aggarwal , B B . 2000 . Anethole blocks both early and late cellular responses transduced by tumor necrosis factor: effect on NF-kappaB, AP-1, JNK, MAPKK and apoptosis . Oncogene , 19 : 2943 – 2950 .
   PubMed Web of Science ®Google Scholar
• Singh , S , Natarajan , K and Aggarwal , B B . 1996 . Capsaicin (8-methyl-N-vanillyl-6-nonenamide) is a potent inhibitor of nuclear transcription factor-kappa B activation by diverse agents . J Immunol , 157 : 4412 – 4420 .
   PubMed Web of Science ®Google Scholar
• Israf , D A , Khaizurin , T A , Syahida , A , Lajis , N H and Khozirah , S . 2007 . Cardamonin inhibits COX and iNOS expression via inhibition of p65NF-kappaB nuclear translocation and Ikappa-B phosphorylation in RAW 264.7 macrophage cells . Mol Immunol , 44 : 673 – 679 .
   PubMed Web of Science ®Google Scholar
• Murakami , R , Uchida , M , Hori , O , Matsuura , N Choshi , T . 2010 . Efficacy of dibenzoylmethane derivatives in protecting against endoplasmic reticulum stress and inhibiting nuclear factor kappa b on dextran sulfate sodium induced colitis in mice . Biol Pharm Bull , 33 : 2029 – 2032 .
   PubMed Web of Science ®Google Scholar
• Shishodia , S and Aggarwal , B B . 2006 . Diosgenin inhibits osteoclastogenesis, invasion, and proliferation through the downregulation of Akt, I kappa B kinase activation and NF-kappa B-regulated gene expression . Oncogene , 25 : 1463 – 1473 .
   PubMed Web of Science ®Google Scholar
• Pandey , M K , Sung , B , Ahn , K S , Kunnumakkara , A B Chaturvedi , M M . 2007 . Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-kappaB signaling pathway . Blood , 110 : 3517 – 3525 .
   PubMed Web of Science ®Google Scholar
• Kim , S O , Chun , K S , Kundu , J K and Surh , Y J . 2004 . Inhibitory effects of [6]-gingerol on PMA-induced COX-2 expression and activation of NF-kappaB and p38 MAPK in mouse skin . Biofactors , 21 : 27 – 31 .
   PubMed Web of Science ®Google Scholar
• Sethi , G , Ahn , K S and Aggarwal , B B . 2008 . Targeting nuclear factor-kappa B activation pathway by thymoquinone: role in suppression of antiapoptotic gene products and enhancement of apoptosis . Mol Cancer Res , 6 : 1059 – 1070 .
   PubMed Web of Science ®Google Scholar
• Harikumar , K B , Kunnumakkara , A B , Ahn , K S , Anand , P Krishnan , S . 2009 . Modification of the cysteine residues in IkappaBalpha kinase and NF-kappaB (p65) by xanthohumol leads to suppression of NF-kappaB-regulated gene products and potentiation of apoptosis in leukemia cells . Blood , 113 : 2003 – 2013 .
   PubMed Web of Science ®Google Scholar
• Shishodia , S , Majumdar , S , Banerjee , S and Aggarwal , B B . 2003 . Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with downregulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1 . Cancer Res , 63 : 4375 – 4383 .
   PubMed Web of Science ®Google Scholar
• Takada , Y , Murakami , A and Aggarwal , B B . 2005 . Zerumbone abolishes NF-kappaB and IkappaBalpha kinase activation leading to suppression of antiapoptotic and metastatic gene expression, upregulation of apoptosis, and downregulation of invasion . Oncogene , 24 : 6957 – 6969 .
   PubMed Web of Science ®Google Scholar
• Akira , S , Nishio , Y , Inoue , M , Wang , X J Wei , S . 1994 . Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway . Cell , 77 : 63 – 71 .
   PubMed Web of Science ®Google Scholar
• Zhong , Z , Wen , Z and Darnell , J E Jr. 1994 . Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6 . Science , 264 : 95 – 98 .
   PubMed Web of Science ®Google Scholar
• Aggarwal , B B , Kunnumakkara , A B , Harikumar , K B , Gupta , S R Tharakan , S T . 2009 . Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship? . Ann NY Acad Sci , 1171 : 59 – 76 .
   PubMed Web of Science ®Google Scholar
• Bharti , A C , Donato , N and Aggarwal , B B . 2003 . Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells . J Immunol , 171 : 3863 – 3871 .
   PubMed Web of Science ®Google Scholar
• Bharti , A C , Shishodia , S , Reuben , J M , Weber , D Alexanian , R . 2004 . Nuclear factor-kappaB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis . Blood , 103 : 3175 – 3184 .
   PubMed Web of Science ®Google Scholar
• Weissenberger , J , Priester , M , Bernreuther , C , Rakel , S Glatzel , M . 2010 . Dietary curcumin attenuates glioma growth in a syngeneic mouse model by inhibition of the JAK1,2/STAT3 signaling pathway . Clin Cancer Res , 16 : 5781 – 5795 .
   PubMed Web of Science ®Google Scholar
• Zhang , C , Li , B , Zhang , X , Hazarika , P Aggarwal , B B . 2010 . Curcumin selectively induces apoptosis in cutaneous T-cell lymphoma cell lines and patients’ PBMCs: potential role for STAT-3 and NF-kappaB signaling . J Invest Dermatol , 130 : 2110 – 2119 .
   PubMed Web of Science ®Google Scholar
• Mackenzie , G G , Queisser , N , Wolfson , M L , Fraga , C G Adamo , A M . 2008 . Curcumin induces cell-arrest and apoptosis in association with the inhibition of constitutively active NF-kappaB and STAT3 pathways in Hodgkin's lymphoma cells . Int J Cancer , 123 : 56 – 65 .
   PubMed Web of Science ®Google Scholar
• Rajasingh , J , Raikwar , H P , Muthian , G , Johnson , C and Bright , J J . 2006 . Curcumin induces growth-arrest and apoptosis in association with the inhibition of constitutively active JAK-STAT pathway in T cell leukemia . Biochem Biophys Res Comm , 340 : 359 – 368 .
   PubMed Web of Science ®Google Scholar
• Saydmohammed , M , Joseph , D and Syed , V . 2010 . Curcumin suppresses constitutive activation of STAT-3 by upregulating protein inhibitor of activated STAT-3 (PIAS-3) in ovarian and endometrial cancer cells . J Cell Biochem , 110 : 447 – 456 .
   PubMed Web of Science ®Google Scholar
• Chakravarti , N , Myers , J N and Aggarwal , B B . 2006 . Targeting constitutive and interleukin-6-inducible signal transducers and activators of transcription 3 pathway in head and neck squamous cell carcinoma cells by curcumin (diferuloylmethane) . Int J Cancer , 119 : 1268 – 1275 .
   PubMed Web of Science ®Google Scholar
• Bhutani , M , Pathak , A K , Nair , A S , Kunnumakkara , A B Guha , S . 2007 . Capsaicin is a novel blocker of constitutive and interleukin-6-inducible STAT3 activation . Clin Cancer Res , 13 : 3024 – 3032 .
   PubMed Web of Science ®Google Scholar
• Lee , H K , Seo , I A , Shin , Y K , Park , J W Suh , D J . 2009 . Capsaicin inhibits the IL-6/STAT3 pathway by depleting intracellular gp130 pools through endoplasmic reticulum stress . Biochem Biophys Res Comm , 382 : 445 – 450 .
   PubMed Web of Science ®Google Scholar
• Li , F , Fernandez , P P , Rajendran , P , Hui , K M and Sethi , G . 2010 . Diosgenin, a steroidal saponin, inhibits STAT3 signaling pathway leading to suppression of proliferation and chemosensitization of human hepatocellular carcinoma cells . Cancer Lett , 292 : 197 – 207 .
   PubMed Web of Science ®Google Scholar
• Li , F , Rajendran , P and Sethi , G . 2010 . Thymoquinone inhibits proliferation, induces apoptosis and chemosensitizes human multiple myeloma cells through suppression of signal transducer and activator of transcription 3 activation pathway . Br J Pharmacol , 161 : 541 – 554 .
   PubMed Web of Science ®Google Scholar
• Pathak , A K , Bhutani , M , Nair , A S , Ahn , K S Chakraborty , A . 2007 . Ursolic acid inhibits STAT3 activation pathway leading to suppression of proliferation and chemosensitization of human multiple myeloma cells . Mol Cancer Res , 5 : 943 – 955 .
   PubMed Web of Science ®Google Scholar
• Schmitt-Ney , M , Happ , B , Ball , R K and Groner , B . 1992 . Developmental and environmental regulation of a mammary gland-specific nuclear factor essential for transcription of the gene encoding beta-casein . Proc Natl Acad Sci USA , 89 : 3130 – 3134 .
   PubMed Web of Science ®Google Scholar
• Wakao , H , Gouilleux , F and Groner , B . 1994 . Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response . EMBO J , 13 : 2182 – 2191 .
   PubMed Web of Science ®Google Scholar
• Lin , J X and Leonard , W J . 2000 . The role of Stat5a and Stat5b in signaling by IL-2 family cytokines . Oncogene , 19 : 2566 – 2576 .
   PubMed Web of Science ®Google Scholar
• Liao , Z , Lutz , J and Nevalainen , M T . 2010 . Transcription factor Stat5a/b as a therapeutic target protein for prostate cancer . Int J Biochem Cell Biol , 42 : 186 – 192 .
   PubMed Web of Science ®Google Scholar
• Bowman , T , Garcia , R , Turkson , J and Jove , R . 2000 . STATs in oncogenesis . Oncogene , 19 : 2474 – 2488 .
   PubMed Web of Science ®Google Scholar
• Buettner , R , Mora , L B and Jove , R . 2002 . Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention . Clin Cancer Res , 8 : 945 – 954 .
   PubMed Web of Science ®Google Scholar
• Huang , M , Dorsey , J F , Epling-Burnette , P K , Nimmanapalli , R Landowski , T H . 2002 . Inhibition of Bcr-Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells . Oncogene , 21 : 8804 – 8816 .
   PubMed Web of Science ®Google Scholar
• Levis , M , Allebach , J , Tse , K F , Zheng , R Baldwin , B R . 2002 . FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo . Blood , 99 : 3885 – 3891 .
   PubMed Web of Science ®Google Scholar
• Li , H , Ahonen , T J , Alanen , K , Xie , J LeBaron , M J . 2004 . Activation of signal transducer and activator of transcription 5 in human prostate cancer is associated with high histological grade . Cancer Res , 64 : 4774 – 4782 .
   PubMed Web of Science ®Google Scholar
• Vafaizadeh , V , Klemmt , P , Brendel , C , Weber , K Doebele , C . 2010 . Mammary epithelial reconstitution with gene-modified stem cells assigns roles to Stat5 in luminal alveolar cell fate decisions, differentiation, involution, and mammary tumor formation . Stem Cells , 28 : 928 – 938 .
   PubMed Web of Science ®Google Scholar
• Blasius , R , Reuter , S , Henry , E , Dicato , M and Diederich , M . 2006 . Curcumin regulates signal transducer and activator of transcription (STAT) expression in K562 cells . Biochem Pharmacol , 72 : 1547 – 1554 .
   PubMed Web of Science ®Google Scholar
• Bernstein , L R and Colburn , N H . 1989 . AP1/jun function is differentially induced in promotion-sensitive and resistant JB6 cells . Science , 244 : 566 – 569 .
   PubMed Web of Science ®Google Scholar
• Brown , P H , Alani , R , Preis , L H , Szabo , E and Birrer , M J . 1993 . Suppression of oncogene-induced transformation by a deletion mutant of c-jun . Oncogene , 8 : 877 – 886 .
   PubMed Web of Science ®Google Scholar
• Dong , Z , Birrer , M J , Watts , R G , Matrisian , L M and Colburn , N H . 1994 . Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells . Proc Natl Acad Sci USA , 91 : 609 – 613 .
   PubMed Web of Science ®Google Scholar
• Shaulian , E and Karin , M . 2002 . AP-1 as a regulator of cell life and death . Nat Cell Biol , 4 : E131 – E136 .
   PubMed Web of Science ®Google Scholar
• Young , M R , Yang , H S and Colburn , N H . 2003 . Promising molecular targets for cancer prevention: AP-1, NF-kappa B, and Pdcd4 . Trends Mol Med , 9 : 36 – 41 .
   PubMed Web of Science ®Google Scholar
• Shaulian , E and Karin , M . 2001 . AP-1 in cell proliferation and survival . Oncogene , 20 : 2390 – 2400 .
   PubMed Web of Science ®Google Scholar
• Eferl , R and Wagner , E F . 2003 . AP-1: a double-edged sword in tumorigenesis . Nat Rev Cancer , 3 : 859 – 868 .
   PubMed Web of Science ®Google Scholar
• Han , S S , Keum , Y S , Seo , H J and Surh , Y J . 2002 . Curcumin suppresses activation of NF-kappaB and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells . J Biochem Mol Biol , 35 : 337 – 342 .
   PubMedGoogle Scholar
• Hergenhahn , M , Soto , U , Weninger , A , Polack , A Hsu , C H . 2002 . The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cells . Mol Carcinog , 33 : 137 – 145 .
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay , A , Bueso-Ramos , C , Chatterjee , D , Pantazis , P and Aggarwal , B B . 2001 . Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines . Oncogene , 20 : 7597 – 7609 .
   PubMed Web of Science ®Google Scholar
• Ichiki , K , Mitani , N , Doki , Y , Hara , H Misaki , T . 2000 . Regulation of activator protein-1 activity in the mediastinal lymph node metastasis of lung cancer . Clin Exp Metastasis , 18 : 539 – 545 .
   PubMed Web of Science ®Google Scholar
• Cha , H J , Park , M T , Chung , H Y , Kim , N D Sato , H . 1998 . Ursolic acid-induced down-regulation of MMP-9 gene is mediated through the nuclear translocation of glucocorticoid receptor in HT1080 human fibrosarcoma cells . Oncogene , 16 : 771 – 778 .
   PubMed Web of Science ®Google Scholar
• Kwak , M K , Wakabayashi , N , Itoh , K , Motohashi , H Yamamoto , M . 2003 . Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival . J Biol Chem , 278 : 8135 – 8145 .
   PubMed Web of Science ®Google Scholar
• Khor , T O , Huang , M T , Prawan , A , Liu , Y Hao , X . 2008 . Increased susceptibility of Nrf2 knockout mice to colitis-associated colorectal cancer . Cancer Prev Res (Phila) , 1 : 187 – 191 .
   PubMed Web of Science ®Google Scholar
• Xu , C , Huang , M T , Shen , G , Yuan , X Lin , W . 2006 . Inhibition of 7,12-dimethylbenz(a)anthracene-induced skin tumorigenesis in C57BL/6 mice by sulforaphane is mediated by nuclear factor E2-related factor 2 . Cancer Res , 66 : 8293 – 8296 .
   PubMed Web of Science ®Google Scholar
• Aoki , Y , Sato , H , Nishimura , N , Takahashi , S Itoh , K . 2001 . Accelerated DNA adduct formation in the lung of the Nrf2 knockout mouse exposed to diesel exhaust . Toxicol Appl Pharmacol , 173 : 154 – 160 .
   PubMed Web of Science ®Google Scholar
• Ramos-Gomez , M , Kwak , M K , Dolan , P M , Itoh , K Yamamoto , M . 2001 . Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice . Proc Natl Acad Sci USA , 98 : 3410 – 3415 .
   PubMed Web of Science ®Google Scholar
• Iida , K , Itoh , K , Kumagai , Y , Oyasu , R Hattori , K . 2004 . Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis . Cancer Res , 64 : 6424 – 6431 .
   PubMed Web of Science ®Google Scholar
• Kitamura , Y , Umemura , T , Kanki , K , Kodama , Y Kitamoto , S . 2007 . Increased susceptibility to hepatocarcinogenicity of Nrf2-deficient mice exposed to 2-amino-3-methylimidazo[4,5-f]quinoline . Cancer Sci , 98 : 19 – 24 .
   PubMed Web of Science ®Google Scholar
• Hayes , J D and McMahon , M . 2009 . NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer . Trends Biochem Sci , 34 : 176 – 188 .
   PubMed Web of Science ®Google Scholar
• Nioi , P and Hayes , J D . 2004 . Contribution of NAD(P)H:quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors . Mutat Res , 555 : 149 – 171 .
   PubMed Web of Science ®Google Scholar
• Shibata , T , Kokubu , A , Gotoh , M , Ojima , H Ohta , T . 2008 . Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer . Gastroenterology , 135 : 1358 – 1368 . e1351–e1354
   PubMed Web of Science ®Google Scholar
• Shibata , T , Ohta , T , Tong , K I , Kokubu , A Odogawa , R . 2008 . Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy . Proc Natl Acad Sci USA , 105 : 13568 – 13573 .
   PubMed Web of Science ®Google Scholar
• Surh , Y J . 2003 . Cancer chemoprevention with dietary phytochemicals . Nat Rev Cancer , 3 : 768 – 780 .
   PubMed Web of Science ®Google Scholar
• Garg , R and Maru , G . 2009 . Dietary curcumin enhances benzo(a)pyrene-induced apoptosis resulting in a decrease in BPDE-DNA adducts in mice . J Environ Pathol Toxicol Oncol , 28 : 121 – 131 .
   PubMed Web of Science ®Google Scholar
• Thimmulappa , R K , Rangasamy , T , Alam , J and Biswal , S . 2008 . Dibenzoylmethane activates Nrf2-dependent detoxification pathway and inhibits benzo(a)pyrene induced DNA adducts in lungs . Med Chem , 4 : 473 – 481 .
   PubMed Web of Science ®Google Scholar
• Cheung , K L , Khor , T O , Huang , M T and Kong , A N . 2010 . Differential in vivo mechanism of chemoprevention of tumor formation in azoxymethane/dextran sodium sulfate mice by PEITC and DBM . Carcinogenesis , 31 : 880 – 885 .
   PubMed Web of Science ®Google Scholar
• Lee , I S , Lim , J , Gal , J , Kang , J C Kim , H J . 2011 . Antiinflammatory activity of xanthohumol involves heme oxygenase-1 induction via NRF2-ARE signaling in microglial BV2 cells . Neurochem Int , 58 : 153 – 160 .
   PubMed Web of Science ®Google Scholar
• Luo , Y , Eggler , A L , Liu , D , Liu , G Mesecar , A D . 2007 . Sites of alkylation of human Keap1 by natural chemoprevention agents . J Am Soc Mass Spectrom , 18 : 2226 – 2232 .
   PubMed Web of Science ®Google Scholar
• Joung , E J , Li , M H , Lee , H G , Somparn , N Jung , Y S . 2007 . Capsaicin induces heme oxygenase-1 expression in HepG2 cells via activation of PI3K-Nrf2 signaling: NAD(P)H:quinone oxidoreductase as a potential target . Antioxid Redox Signal , 9 : 2087 – 2098 .
   PubMed Web of Science ®Google Scholar
• Evans , R M . 2005 . The nuclear receptor superfamily: a Rosetta stone for physiology . Mol Endocrinol , 19 : 1429 – 1438 .
   PubMed Web of Science ®Google Scholar
• Grommes , C , Landreth , G E and Heneka , M T . 2004 . Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists . Lancet Oncol , 5 : 419 – 429 .
   PubMed Web of Science ®Google Scholar
• Nahle , Z . 2004 . PPAR trilogy from metabolism to cancer . Curr Opin Clin Nutr Metab Care , 7 : 397 – 402 .
   PubMed Web of Science ®Google Scholar
• Panigrahy , D , Huang , S , Kieran , M W and Kaipainen , A . 2005 . PPARgamma as a therapeutic target for tumor angiogenesis and metastasis . Cancer Biol Ther , 4 : 687 – 693 .
   PubMed Web of Science ®Google Scholar
• Altiok , S , Xu , M and Spiegelman , B M . 1997 . PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via downregulation of PP2A . Genes Dev , 11 : 1987 – 1998 .
   PubMed Web of Science ®Google Scholar
• Qin , C , Morrow , D , Stewart , J , Spencer , K Porter , W . 2004 . A new class of peroxisome proliferator-activated receptor gamma (PPARgamma) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3’-indolyl)-1-(p-substituted phenyl)methanes . Mol Cancer Ther , 3 : 247 – 260 .
   PubMed Web of Science ®Google Scholar
• Sato , H , Ishihara , S , Kawashima , K , Moriyama , N Suetsugu , H . 2000 . Expression of peroxisome proliferator-activated receptor (PPAR)gamma in gastric cancer and inhibitory effects of PPARgamma agonists . Br J Cancer , 83 : 1394 – 1400 .
   PubMed Web of Science ®Google Scholar
• Yoshimura , R , Matsuyama , M , Segawa , Y , Hase , T Mitsuhashi , M . 2003 . Expression of peroxisome proliferator-activated receptors (PPARs) in human urinary bladder carcinoma and growth inhibition by its agonists . Int J Cancer , 104 : 597 – 602 .
   PubMed Web of Science ®Google Scholar
• Hamakawa , H , Nakashiro , K , Sumida , T , Shintani , S Myers , J N . 2008 . Basic evidence of molecular targeted therapy for oral cancer and salivary gland cancer . Head Neck , 30 : 800 – 809 .
   PubMed Web of Science ®Google Scholar
• Kroll , T G , Sarraf , P , Pecciarini , L , Chen , C J Mueller , E . 2000 . PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected] . Science , 289 : 1357 – 1360 .
   PubMed Web of Science ®Google Scholar
• Sarraf , P , Mueller , E , Smith , W M , Wright , H M Kum , J B . 1999 . Loss-of-function mutations in PPAR gamma associated with human colon cancer . Mol Cell , 3 : 799 – 804 .
   PubMed Web of Science ®Google Scholar
• Khuri , F R , Lee , J J , Lippman , S M , Kim , E S Cooper , J S . 2006 . Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients . J Natl Cancer Inst , 98 : 441 – 450 .
   PubMed Web of Science ®Google Scholar
• O’Shaughnessy , J A , Kelloff , G J , Gordon , G B , Dannenberg , A J Hong , W K . 2002 . Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development . Clin Cancer Res , 8 : 314 – 346 .
   PubMed Web of Science ®Google Scholar
• Chen , A and Xu , J . 2005 . Activation of PPAR{gamma} by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR . Am J Physiol Gastrointest Liver Physiol , 288 : G447 – 456 .
   PubMed Web of Science ®Google Scholar
• Kim , C S , Park , W H , Park , J Y , Kang , J H Kim , M O . 2004 . Capsaicin, a spicy component of hot pepper, induces apoptosis by activation of the peroxisome proliferator-activated receptor gamma in HT-29 human colon cancer cells . J Med Food , 7 : 267 – 273 .
   PubMed Web of Science ®Google Scholar
• Nusse , R and Varmus , H E . 1982 . Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome . Cell , 31 : 99 – 109 .
   PubMed Web of Science ®Google Scholar
• Willert , K , Brown , J D , Danenberg , E , Duncan , A W Weissman , I L . 2003 . Wnt proteins are lipid-modified and can act as stem cell growth factors . Nature , 423 : 448 – 452 .
   PubMed Web of Science ®Google Scholar
• Chien , A J , Conrad , W H and Moon , R T . 2009 . A Wnt survival guide: from flies to human disease . J Invest Dermatol , 129 : 1614 – 1627 .
   PubMed Web of Science ®Google Scholar
• Jaiswal , A S , Marlow , B P , Gupta , N and Narayan , S . 2002 . Beta-catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells . Oncogene , 21 : 8414 – 8427 .
   PubMed Web of Science ®Google Scholar
• Ryu , M J , Cho , M , Song , J Y , Yun , Y S Choi , I W . 2008 . Natural derivatives of curcumin attenuate the Wnt/beta-catenin pathway through down-regulation of the transcriptional coactivator p300 . Biochem Biophys Res Comm , 377 : 1304 – 1308 .
   PubMed Web of Science ®Google Scholar
• Prasad , C P , Rath , G , Mathur , S , Bhatnagar , D and Ralhan , R . 2009 . Potent growth suppressive activity of curcumin in human breast cancer cells: modulation of Wnt/beta-catenin signaling . Chem Biol Interact , 181 : 263 – 271 .
   PubMed Web of Science ®Google Scholar
• Kakarala , M , Brenner , D E , Korkaya , H , Cheng , C Tazi , K . 2010 . Targeting breast stem cells with the cancer preventive compounds curcumin and piperine . Breast Cancer Res Treat , 122 : 777 – 785 .
   PubMed Web of Science ®Google Scholar
• Choi , Y H , Baek , J H , Yoo , M A , Chung , H Y Kim , N D . 2000 . Induction of apoptosis by ursolic acid through activation of caspases and down-regulation of c-IAPs in human prostate epithelial cells . Int J Oncol , 17 : 565 – 571 .
   PubMed Web of Science ®Google Scholar
• Vanhoecke , B , Derycke , L , Van Marck , V , Depypere , H De Keukeleire , D . 2005 . Antiinvasive effect of xanthohumol, a prenylated chalcone present in hops (Humulus lupulus L.) and beer . Int J Cancer , 117 : 889 – 895 .
   PubMed Web of Science ®Google Scholar
• Nusslein-Volhard , C and Wieschaus , E . 1980 . Mutations affecting segment number and polarity in Drosophila . Nature , 287 : 795 – 801 .
   PubMed Web of Science ®Google Scholar
• Ingham , P W and McMahon , A P . 2001 . Hedgehog signaling in animal development: paradigms and principles . Genes Dev , 15 : 3059 – 3087 .
   PubMed Web of Science ®Google Scholar
• Beachy , P A , Karhadkar , S S and Berman , D M . 2004 . Tissue repair and stem cell renewal in carcinogenesis . Nature , 432 : 324 – 331 .
   PubMed Web of Science ®Google Scholar
• Jiang , J and Hui , C C . 2008 . Hedgehog signaling in development and cancer . Dev Cell , 15 : 801 – 812 .
   PubMed Web of Science ®Google Scholar
• Yang , L , Xie , G , Fan , Q and Xie , J . 2010 . Activation of the hedgehog-signaling pathway in human cancer and the clinical implications . Oncogene , 29 : 469 – 481 .
   PubMed Web of Science ®Google Scholar
• Wang , L H , Choi , Y L , Hua , X Y , Shin , Y K Song , Y J . 2006 . Increased expression of sonic hedgehog and altered methylation of its promoter region in gastric cancer and its related lesions . Mod Pathol , 19 : 675 – 683 .
   PubMed Web of Science ®Google Scholar
• Fukaya , M , Isohata , N , Ohta , H , Aoyagi , K Ochiya , T . 2006 . Hedgehog signal activation in gastric pit cell and in diffuse-type gastric cancer . Gastroenterology , 131 : 14 – 29 .
   PubMed Web of Science ®Google Scholar
• Elamin , M H , Shinwari , Z , Hendrayani , S F , Al-Hindi , H Al-Shail , E . 2010 . Curcumin inhibits the sonic hedgehog signaling pathway and triggers apoptosis in medulloblastoma cells . Mol Carcinog , 49 : 302 – 314 .
   PubMed Web of Science ®Google Scholar
• Hosoya , T , Arai , M A , Koyano , T , Kowithayakorn , T and Ishibashi , M . 2008 . Naturally occurring small-molecule inhibitors of hedgehog/GLI-mediated transcription . Chembiochem , 9 : 1082 – 1092 .
   PubMed Web of Science ®Google Scholar
• Gregory , H . 1975 . Isolation and structure of urogastrone and its relationship to epidermal growth factor . Nature , 257 : 325 – 327 .
   PubMed Web of Science ®Google Scholar
• Carpenter , G and Cohen , S . 1979 . Epidermal growth factor . Annu Rev Biochem , 48 : 193 – 216 .
   PubMed Web of Science ®Google Scholar
• Lo , H W and Hung , M C . 2006 . Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival . Br J Cancer , 94 : 184 – 188 .
   PubMed Web of Science ®Google Scholar
• Sporn , M B and Todaro , G J . 1980 . Autocrine secretion and malignant transformation of cells . N Engl J Med , 303 : 878 – 880 .
   PubMed Web of Science ®Google Scholar
• Korutla , L , Cheung , J Y , Mendelsohn , J and Kumar , R . 1995 . Inhibition of ligand-induced activation of epidermal growth factor receptor tyrosine phosphorylation by curcumin . Carcinogenesis , 16 : 1741 – 1745 .
   PubMed Web of Science ®Google Scholar
• Squires , M S , Hudson , E A , Howells , L , Sale , S Houghton , C E . 2003 . Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells . Biochem Pharmacol , 65 : 361 – 376 .
   PubMed Web of Science ®Google Scholar
• Kim , J H , Xu , C , Keum , Y S , Reddy , B Conney , A . 2006 . Inhibition of EGFR signaling in human prostate cancer PC-3 cells by combination treatment with beta-phenylethyl isothiocyanate and curcumin . Carcinogenesis , 27 : 475 – 482 .
   PubMed Web of Science ®Google Scholar
• Lev-Ari , S , Starr , A , Vexler , A , Karaush , V Loew , V . 2006 . Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, downregulation of COX-2 and EGFR and inhibition of Erk1/2 activity . Anticancer Res , 26 : 4423 – 4430 .
   PubMed Web of Science ®Google Scholar
• Khafif , A , Lev-Ari , S , Vexler , A , Barnea , I Starr , A . 2009 . Curcumin: a potential radio-enhancer in head and neck cancer . Laryngoscope , 119 : 2019 – 2026 .
   PubMed Web of Science ®Google Scholar
• Shan , J Z , Xuan , Y Y , Zheng , S , Dong , Q and Zhang , S Z . 2009 . Ursolic acid inhibits proliferation and induces apoptosis of HT-29 colon cancer cells by inhibiting the EGFR/MAPK pathway . J Zhejiang Univ Sci B , 10 : 668 – 674 .
   PubMed Web of Science ®Google Scholar
• Thoennissen , N H , O’Kelly , J , Lu , D , Iwanski , G B La , D T . 2010 . Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway . Oncogene , 29 : 285 – 296 .
   PubMed Web of Science ®Google Scholar
• Lee , E J , Jeon , M S , Kim , B D , Kim , J H Kwon , Y G . 2010 . Capsiate inhibits ultraviolet B-induced skin inflammation by inhibiting Src family kinases and epidermal growth factor receptor signaling . Free Radic Biol Med , 48 : 1133 – 1143 .
   PubMed Web of Science ®Google Scholar
• Schlessinger , J . 2000 . Cell signaling by receptor tyrosine kinases . Cell , 103 : 211 – 225 .
   PubMed Web of Science ®Google Scholar
• Gullick , W J . 2001 . Update on HER-2 as a target for cancer therapy: alternative strategies for targeting the epidermal growth factor system in cancer . Breast Cancer Res , 3 : 390 – 394 .
   PubMed Web of Science ®Google Scholar
• Molina , M A , Codony-Servat , J , Albanell , J , Rojo , F Arribas , J . 2001 . Trastuzumab (herceptin), a humanized anti-Her2 receptor monoclonal antibody, inhibits basal and activated Her2 ectodomain cleavage in breast cancer cells . Cancer Res , 61 : 4744 – 4749 .
   PubMed Web of Science ®Google Scholar
• Hong , R L , Spohn , W H and Hung , M C . 1999 . Curcumin inhibits tyrosine kinase activity of p185neu and also depletes p185neu . Clin Cancer Res , 5 : 1884 – 1891 .
   PubMed Web of Science ®Google Scholar
• Jung , Y , Xu , W , Kim , H , Ha , N and Neckers , L . 2007 . Curcumin-induced degradation of ErbB2: A role for the E3 ubiquitin ligase CHIP and the Michael reaction acceptor activity of curcumin . Biochim Biophys Acta , 1773 : 383 – 390 .
   PubMed Web of Science ®Google Scholar
• Cai , X Z , Wang , J , Li , X D , Wang , G L Liu , F N . 2009 . Curcumin suppresses proliferation and invasion in human gastric cancer cells by downregulation of PAK1 activity and cyclin D1 expression . Cancer Biol Ther , 8 : 1360 – 1368 .
   PubMed Web of Science ®Google Scholar
• Terman , B I , Dougher-Vermazen , M , Carrion , M E , Dimitrov , D Armellino , D C . 1992 . Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor . Biochem Biophys Res Comm , 187 : 1579 – 1586 .
   PubMed Web of Science ®Google Scholar
• Pajusola , K , Aprelikova , O , Korhonen , J , Kaipainen , A Pertovaara , L . 1992 . FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines . Cancer Res , 52 : 5738 – 5743 .
   PubMed Web of Science ®Google Scholar
• Barleon , B , Siemeister , G , Martiny-Baron , G , Weindel , K Herzog , C . 1997 . Vascular endothelial growth factor upregulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells . Cancer Res , 57 : 5421 – 5425 .
   PubMed Web of Science ®Google Scholar
• Kim , E C , Min , J K , Kim , T Y , Lee , S J Yang , H O . 2005 . [6]-Gingerol, a pungent ingredient of ginger, inhibits angiogenesis in vitro and in vivo . Biochem Biophys Res Comm , 335 : 300 – 308 .
   PubMed Web of Science ®Google Scholar
• Yi , T , Yi , Z , Cho , S G , Luo , J Pandey , M K . 2008 . Gambogic acid inhibits angiogenesis and prostate tumor growth by suppressing vascular endothelial growth factor receptor 2 signaling . Cancer Res , 68 : 1843 – 1850 .
   PubMed Web of Science ®Google Scholar
• Casa , A J , Dearth , R K , Litzenburger , B C , Lee , A V and Cui , X . 2008 . The type I insulin-like growth factor receptor pathway: a key player in cancer therapeutic resistance . Front Biosci , 13 : 3273 – 3287 .
   PubMed Web of Science ®Google Scholar
• Kim , S Y , Toretsky , J A , Scher , D and Helman , L J . 2009 . The role of IGF-1R in pediatric malignancies . Oncologist , 14 : 83 – 91 .
   PubMed Web of Science ®Google Scholar
• Sachdev , D and Yee , D . 2007 . Disrupting insulin-like growth factor signaling as a potential cancer therapy . Mol Cancer Ther , 6 : 1 – 12 .
   PubMed Web of Science ®Google Scholar
• Allen , N E , Roddam , A W , Allen , D S , Fentiman , I S Dos Santos Silva , I . 2005 . A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk . Br J Cancer , 92 : 1283 – 1287 .
   PubMed Web of Science ®Google Scholar
• Stattin , P , Bylund , A , Rinaldi , S , Biessy , C Dechaud , H . 2000 . Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study . J Natl Cancer Inst , 92 : 1910 – 1917 .
   PubMed Web of Science ®Google Scholar
• Yu , H , Spitz , M R , Mistry , J , Gu , J Hong , W K . 1999 . Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis . J Natl Cancer Inst , 91 : 151 – 156 .
   PubMed Web of Science ®Google Scholar
• Ma , J , Pollak , M N , Giovannucci , E , Chan , J M Tao , Y . 1999 . Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3 . J Natl Cancer Inst , 91 : 620 – 625 .
   PubMed Web of Science ®Google Scholar
• Zhao , H , Grossman , H B , Spitz , M R , Lerner , S P Zhang , K . 2003 . Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk . J Urol , 169 : 714 – 717 .
   PubMed Web of Science ®Google Scholar
• Xia , Y , Jin , L , Zhang , B , Xue , H Li , Q . 2007 . The potentiation of curcumin on insulin-like growth factor-1 action in MCF-7 human breast carcinoma cells . Life Sci , 80 : 2161 – 2169 .
   PubMed Web of Science ®Google Scholar
• Heldin , C H , Johnsson , A , Wennergren , S , Wernstedt , C Betsholtz , C . 1986 . A human osteosarcoma cell line secretes a growth factor structurally related to a homodimer of PDGF A-chains . Nature , 319 : 511 – 514 .
   PubMed Web of Science ®Google Scholar
• Li , X , Ponten , A , Aase , K , Karlsson , L Abramsson , A . 2000 . PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor . Nat Cell Biol , 2 : 302 – 309 .
   PubMed Web of Science ®Google Scholar
• Levitzki , A . 2004 . PDGF receptor kinase inhibitors for the treatment of PDGF driven diseases . Cytokine Growth Factor Rev , 15 : 229 – 235 .
   PubMed Web of Science ®Google Scholar
• Rikova , K , Guo , A , Zeng , Q , Possemato , A Yu , J . 2007 . Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer . Cell , 131 : 1190 – 1203 .
   PubMed Web of Science ®Google Scholar
• Yang , X , Thomas , D P , Zhang , X , Culver , B W Alexander , B M . 2006 . Curcumin inhibits platelet-derived growth factor-stimulated vascular smooth muscle cell function and injury-induced neointima formation . Arterioscler Thromb Vasc Biol , 26 : 85 – 90 .
   PubMed Web of Science ®Google Scholar
• Lin , J and Chen , A . 2008 . Activation of peroxisome proliferator-activated receptor-gamma by curcumin blocks the signaling pathways for PDGF and EGF in hepatic stellate cells . Lab Invest , 88 : 529 – 540 .
   PubMed Web of Science ®Google Scholar
• Zhao , Z D and Huang , Z S . 2009 . [Study on effects of curcumin on expressions of PDGF-BB, PDGFRbeta and ERK1 of HSC] . Zhong Yao Cai , 32 : 732 – 735 .
   PubMedGoogle Scholar
• Liu , Y , Dolence , J , Ren , J , Rao , M and Sreejayan , N . 2008 . Inhibitory effect of dehydrozingerone on vascular smooth muscle cell function . J Cardiovasc Pharmacol , 52 : 422 – 429 .
   PubMed Web of Science ®Google Scholar
• Liu , Y , Li , W , Ye , C , Lin , Y Cheang , T Y . 2010 . Gambogic acid induces G0/G1 cell cycle arrest and cell migration inhibition via suppressing PDGF receptor beta tyrosine phosphorylation and Rac1 activity in rat aortic smooth muscle cells . J Atheroscler Thromb , 17 : 901 – 913 .
   PubMed Web of Science ®Google Scholar
• Vanhaesebroeck , B , Leevers , S J , Ahmadi , K , Timms , J Katso , R . 2001 . Synthesis and function of 3-phosphorylated inositol lipids . Annu Rev Biochem , 70 : 535 – 602 .
   PubMed Web of Science ®Google Scholar
• Shayesteh , L , Lu , Y , Kuo , W L , Baldocchi , R Godfrey , T . 1999 . PIK3CA is implicated as an oncogene in ovarian cancer . Nat Genet , 21 : 99 – 102 .
   PubMed Web of Science ®Google Scholar
• Li , S Y , Rong , M , Grieu , F and Iacopetta , B . 2006 . PIK3CA mutations in breast cancer are associated with poor outcome . Breast Cancer Res Treat , 96 : 91 – 95 .
   PubMed Web of Science ®Google Scholar
• Samuels , Y , Wang , Z , Bardelli , A , Silliman , N Ptak , J . 2004 . High frequency of mutations of the PIK3CA gene in human cancers . Science , 304 : 554
   PubMed Web of Science ®Google Scholar
• Deane , J A and Fruman , D A . 2004 . Phosphoinositide 3-kinase: diverse roles in immune cell activation . Annu Rev Immunol , 22 : 563 – 598 .
   PubMed Web of Science ®Google Scholar
• Achiwa , Y , Hasegawa , K and Udagawa , Y . 2007 . Regulation of the phosphatidylinositol 3-kinase-Akt and the mitogen-activated protein kinase pathways by ursolic acid in human endometrial cancer cells . Biosci Biotechnol Biochem , 71 : 31 – 37 .
   PubMed Web of Science ®Google Scholar
• Tang , C , Lu , Y H , Xie , J H , Wang , F Zou , J N . 2009 . Downregulation of survivin and activation of caspase-3 through the PI3K/Akt pathway in ursolic acid-induced HepG2 cell apoptosis . Anticancer Drugs , 20 : 249 – 258 .
   PubMed Web of Science ®Google Scholar
• Lee , J , Jung , K , Kim , Y S and Park , D . 2007 . Diosgenin inhibits melanogenesis through the activation of phosphatidylinositol-3-kinase pathway (PI3K) signaling . Life Sci , 81 : 249 – 254 .
   PubMed Web of Science ®Google Scholar
• Hussain , A R , Al-Rasheed , M , Manogaran , P S , Al-Hussein , K A Platanias , L C . 2006 . Curcumin induces apoptosis via inhibition of PI3’-kinase/AKT pathway in acute T cell leukemias . Apoptosis , 11 : 245 – 254 .
   PubMed Web of Science ®Google Scholar
• Chen , L X , He , Y J , Zhao , S Z , Wu , J G Wang , J T . 2011 . Inhibition of tumor growth and vasculogenic mimicry by cucumin through downregulation of the EphA2/PI3K/MMP pathway in a murine choroidal melanoma model . Cancer Biol Ther , 11
   Web of Science ®Google Scholar
• Carling , D , Zammit , V A and Hardie , D G . 1987 . A common bicyclic protein kinase cascade inactivates the regulatory enzymes of fatty acid and cholesterol biosynthesis . FEBS Lett , 223 : 217 – 222 .
   PubMed Web of Science ®Google Scholar
• Hardie , D G . 2007 . AMP-activated protein kinase as a drug target . Annu Rev Pharmacol Toxicol , 47 : 185 – 210 .
   PubMed Web of Science ®Google Scholar
• Ruderman , N and Prentki , M . 2004 . AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome . Nat Rev Drug Discov , 3 : 340 – 351 .
   PubMed Web of Science ®Google Scholar
• Inoki , K , Zhu , T and Guan , K L . 2003 . TSC2 mediates cellular energy response to control cell growth and survival . Cell , 115 : 577 – 590 .
   PubMed Web of Science ®Google Scholar
• Fay , J R , Steele , V and Crowell , J A . 2009 . Energy homeostasis and cancer prevention: the AMP-activated protein kinase . Cancer Prev Res (Phila) , 2 : 301 – 309 .
   PubMed Web of Science ®Google Scholar
• Luo , Z , Zang , M and Guo , W . 2010 . AMPK as a metabolic tumor suppressor: control of metabolism and cell growth . Future Oncol , 6 : 457 – 470 .
   PubMed Web of Science ®Google Scholar
• Pan , W , Yang , H , Cao , C , Song , X Wallin , B . 2008 . AMPK mediates curcumin-induced cell death in CaOV3 ovarian cancer cells . Oncol Rep , 20 : 1553 – 1559 .
   PubMed Web of Science ®Google Scholar
• Lee , Y K , Lee , W S , Hwang , J T , Kwon , D Y Surh , Y J . 2009 . Curcumin exerts antidifferentiation effect through AMPKalpha-PPAR-gamma in 3T3-L1 adipocytes and antiproliferatory effect through AMPKalpha-COX-2 in cancer cells . J Agric Food Chem , 57 : 305 – 310 .
   PubMed Web of Science ®Google Scholar
• Lee , Y K , Park , S Y , Kim , Y M and Park , O J . 2009 . Regulatory effect of the AMPK-COX-2 signaling pathway in curcumin-induced apoptosis in HT-29 colon cancer cells . Ann NY Acad Sci , 1171 : 489 – 494 .
   PubMed Web of Science ®Google Scholar
• Kim , Y M , Hwang , J T , Kwak , D W , Lee , Y K and Park , O J . 2007 . Involvement of AMPK signaling cascade in capsaicin-induced apoptosis of HT-29 colon cancer cells . Ann NY Acad Sci , 1095 : 496 – 503 .
   PubMed Web of Science ®Google Scholar
• Zou , X and Calame , K . 1999 . Signaling pathways activated by oncogenic forms of Abl tyrosine kinase . J Biol Chem , 274 : 18141 – 18144 .
   PubMed Web of Science ®Google Scholar
• Bedi , A , Barber , J P , Bedi , G C , el-Deiry , W S Sidransky , D . 1995 . BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agents . Blood , 86 : 1148 – 1158 .
   PubMed Web of Science ®Google Scholar
• Sanchez-Garcia , I and Grutz , G . 1995 . Tumorigenic activity of the BCR-ABL oncogenes is mediated by BCL2 . Proc Natl Acad Sci USA , 92 : 5287 – 5291 .
   PubMed Web of Science ®Google Scholar
• Burgess , G S , Williamson , E A , Cripe , L D , Litz-Jackson , S Bhatt , J A . 1998 . Regulation of the c-jun gene in p210 BCR-ABL transformed cells corresponds with activity of JNK, the c-jun N-terminal kinase . Blood , 92 : 2450 – 2460 .
   PubMed Web of Science ®Google Scholar
• Jagani , Z , Song , K , Kutok , J L , Dewar , M R Melet , A . 2009 . Proteasome inhibition causes regression of leukemia and abrogates BCR-ABL-induced evasion of apoptosis in part through regulation of forkhead tumor suppressors . Cancer Res , 69 : 6546 – 6555 .
   PubMed Web of Science ®Google Scholar
• Wu , L X , Xu , J H , Wu , G H and Chen , Y Z . 2003 . Inhibitory effect of curcumin on proliferation of K562 cells involves down-regulation of p210(bcr/abl) initiated Ras signal transduction pathway . Acta Pharmacol Sin , 24 : 1155 – 1160 .
   PubMed Web of Science ®Google Scholar
• Wu , L X , Xu , J H , Huang , X W , Zhang , K Z Wen , C X . 2006 . Downregulation of p210(bcr/abl) by curcumin involves disrupting molecular chaperone functions of Hsp90 . Acta Pharmacol Sin , 27 : 694 – 699 .
   PubMed Web of Science ®Google Scholar
• William , B M , Goodrich , A , Peng , C and Li , S . 2008 . Curcumin inhibits proliferation and induces apoptosis of leukemic cells expressing wild-type or T315I-BCR-ABL and prolongs survival of mice with acute lymphoblastic leukemia . Hematology , 13 : 333 – 343 .
   PubMed Web of Science ®Google Scholar
• Monteghirfo , S , Tosetti , F , Ambrosini , C , Stigliani , S Pozzi , S . 2008 . Antileukemia effects of xanthohumol in Bcr/Abl-transformed cells involve nuclear factor-kappaB and p53 modulation . Mol Cancer Ther , 7 : 2692 – 2702 .
   PubMed Web of Science ®Google Scholar
• Daum , G , Eisenmann-Tappe , I , Fries , H W , Troppmair , J and Rapp , U R . 1994 . The ins and outs of Raf kinases . Trends Biochem Sci , 19 : 474 – 480 .
   PubMed Web of Science ®Google Scholar
• Wiesmuller , L and Wittinghofer , F . 1994 . Signal transduction pathways involving Ras. Mini review . Cell Signal , 6 : 247 – 267 .
   PubMed Web of Science ®Google Scholar
• Wellbrock , C , Karasarides , M and Marais , R . 2004 . The RAF proteins take centre stage . Nat Rev Mol Cell Biol , 5 : 875 – 885 .
   PubMed Web of Science ®Google Scholar
• Limtrakul , P , Anuchapreeda , S , Lipigorngoson , S and Dunn , F W . 2001 . Inhibition of carcinogen induced c-Ha-ras and c-fos proto-oncogenes expression by dietary curcumin . BMC Cancer , 1 : 1
   PubMed Web of Science ®Google Scholar
• Faivre , S , Kroemer , G and Raymond , E . 2006 . Current development of mTOR inhibitors as anticancer agents . Nat Rev Drug Discov , 5 : 671 – 688 .
   PubMed Web of Science ®Google Scholar
• Ciuffreda , L , Di Sanza , C , Incani , U C and Milella , M . 2010 . The mTOR pathway: a new target in cancer therapy . Curr Cancer Drug Targets , 10 : 484 – 495 .
   PubMed Web of Science ®Google Scholar
• Sun , Z J , Chen , G , Zhang , W , Hu , X Liu , Y . 2011 . Curcumin dually inhibits both mTOR and NF-{kappa}B pathways through a crossed PI3K/Akt/IKK signaling axis in adenoid cystic carcinoma . Mol Pharmacol , 79 : 106 – 118 .
   PubMed Web of Science ®Google Scholar
• Rafiee , P , Binion , D G , Wellner , M , Behmaram , B Floer , M . 2010 . Modulatory effect of curcumin on survival of irradiated human intestinal microvascular endothelial cells: role of Akt/mTOR and NF-{kappa}B . Am J Physiol Gastrointest Liver Physiol , 298 : G865 – 877 .
   PubMed Web of Science ®Google Scholar
• Clark , C A , McEachern , M D , Shah , S H , Rong , Y Rong , X . 2010 . Curcumin inhibits carcinogen and nicotine-induced mammalian target of rapamycin pathway activation in head and neck squamous cell carcinoma . Cancer Prev Res (Phila) ,
   Google Scholar
• Su , C C , Wang , M J and Chiu , T L . 2010 . The anti-cancer efficacy of curcumin scrutinized through core signaling pathways in glioblastoma . Int J Mol Med , 26 : 217 – 224 .
   PubMed Web of Science ®Google Scholar
• Shinojima , N , Yokoyama , T , Kondo , Y and Kondo , S . 2007 . Roles of the Akt/mTOR/p70S6K and ERK1/2 signaling pathways in curcumin-induced autophagy . Autophagy , 3 : 635 – 637 .
   PubMed Web of Science ®Google Scholar
• Aoki , H , Takada , Y , Kondo , S , Sawaya , R Aggarwal , B B . 2007 . Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways . Mol Pharmacol , 72 : 29 – 39 .
   PubMed Web of Science ®Google Scholar
• Johnson , S M , Gulhati , P , Arrieta , I , Wang , X Uchida , T . 2009 . Curcumin inhibits proliferation of colorectal carcinoma by modulating Akt/mTOR signaling . Anticancer Res , 29 : 3185 – 3190 .
   PubMed Web of Science ®Google Scholar
• Li , M , Zhang , Z , Hill , D L , Wang , H and Zhang , R . 2007 . Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway . Cancer Res , 67 : 1988 – 1996 .
   PubMed Web of Science ®Google Scholar
• Yu , S , Shen , G , Khor , T O , Kim , J H and Kong , A N . 2008 . Curcumin inhibits Akt/mammalian target of rapamycin signaling through protein phosphatase-dependent mechanism . Mol Cancer Ther , 7 : 2609 – 2620 .
   PubMed Web of Science ®Google Scholar
• Beevers , C S , Chen , L , Liu , L , Luo , Y Webster , N J . 2009 . Curcumin disrupts the Mammalian target of rapamycin-raptor complex . Cancer Res , 69 : 1000 – 1008 .
   PubMed Web of Science ®Google Scholar
• Deeb , D , Gao , X , Jiang , H , Arbab , A S Dulchavsky , S A . 2010 . Growth inhibitory and apoptosis-inducing effects of xanthohumol, a prenylated chalone present in hops, in human prostate cancer cells . Anticancer Res , 30 : 3333 – 3339 .
   PubMed Web of Science ®Google Scholar
• Chiang , C T , Way , T D , Tsai , S J and Lin , J K . 2007 . Diosgenin, a naturally occurring steroid, suppresses fatty acid synthase expression in HER2-overexpressing breast cancer cells through modulating Akt, mTOR and JNK phosphorylation . FEBS Lett , 581 : 5735 – 5742 .
   PubMed Web of Science ®Google Scholar
• De Angel , R E , Smith , S M , Glickman , R D , Perkins , S N and Hursting , S D . 2010 . Antitumor effects of ursolic acid in a mouse model of postmenopausal breast cancer . Nutr Cancer , 62 : 1074 – 1086 .
   PubMed Web of Science ®Google Scholar
• Aggarwal , B B . 2003 . Signalling pathways of the TNF superfamily: a double-edged sword . Nat Rev Immunol , 3 : 745 – 756 .
   PubMed Web of Science ®Google Scholar
• Balkwill , F . 2002 . Tumor necrosis factor or tumor promoting factor? . Cytokine Growth Factor Rev , 13 : 135 – 141 .
   PubMed Web of Science ®Google Scholar
• Sugarman , B J , Aggarwal , B B , Hass , P E , Figari , I S Palladino , M A Jr. 1985 . Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro . Science , 230 : 943 – 945 .
   PubMed Web of Science ®Google Scholar
• Shishodia , S , Amin , H M , Lai , R and Aggarwal , B B . 2005 . Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma . Biochem Pharmacol , 70 : 700 – 713 .
   PubMed Web of Science ®Google Scholar
• Surh , Y J , Park , K K , Chun , K S , Lee , L J Lee , E . 1999 . Antitumor-promoting activities of selected pungent phenolic substances present in ginger . J Environ Pathol Toxicol Oncol , 18 : 131 – 139 .
   PubMedGoogle Scholar
• Ahmad , S , Israf , D A , Lajis , N H , Shaari , K Mohamed , H . 2006 . Cardamonin, inhibits pro-inflammatory mediators in activated RAW 264.7 cells and whole blood . Eur J Pharmacol , 538 : 188 – 194 .
   PubMed Web of Science ®Google Scholar
• Lee , Y Y , Hung , S L , Pai , S F , Lee , Y H and Yang , S F . 2007 . Eugenol suppressed the expression of lipopolysaccharide-induced proinflammatory mediators in human macrophages . J Endod , 33 : 698 – 702 .
   PubMed Web of Science ®Google Scholar
• Kaur , G , Athar , M and Alam , M S . 2010 . Eugenol precludes cutaneous chemical carcinogenesis in mouse by preventing oxidative stress and inflammation and by inducing apoptosis . Mol Carcinog , 49 : 290 – 301 .
   PubMed Web of Science ®Google Scholar
• Zhang , L , Yi , Y , Chen , J , Sun , Y Guo , Q . 2010 . Gambogic acid inhibits Hsp90 and deregulates TNF-alpha/NF-kappaB in HeLa cells . Biochem Biophys Res Commun , 403 : 282 – 287 .
   PubMed Web of Science ®Google Scholar
• El-Mahmoudy , A , Shimizu , Y , Shiina , T , Matsuyama , H Nikami , H . 2005 . Macrophage-derived cytokine and nitric oxide profiles in type I and type II diabetes mellitus: effect of thymoquinone . Acta Diabetol , 42 : 23 – 30 .
   PubMed Web of Science ®Google Scholar
• Tekeoglu , I , Dogan , A and Demiralp , L . 2006 . Effects of thymoquinone (volatile oil of black cumin) on rheumatoid arthritis in rat models . Phytother Res , 20 : 869 – 871 .
   PubMed Web of Science ®Google Scholar
• Murakami , A , Hayashi , R , Tanaka , T , Kwon , K H Ohigashi , H . 2003 . Suppression of dextran sodium sulfate-induced colitis in mice by zerumbone, a subtropical ginger sesquiterpene, and nimesulide: separately and in combination . Biochem Pharmacol , 66 : 1253 – 1261 .
   PubMed Web of Science ®Google Scholar
• Lupinacci , E , Meijerink , J , Vincken , J P , Gabriele , B Gruppen , H . 2009 . Xanthohumol from hop (Humulus lupulus L.) is an efficient inhibitor of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha release in LPS-stimulated RAW 264.7 mouse macrophages and U937 human monocytes . J Agric Food Chem , 57 : 7274 – 7281 .
   PubMed Web of Science ®Google Scholar
• Arlt , A , Vorndamm , J , Muerkoster , S , Yu , H Schmidt , W E . 2002 . Autocrine production of interleukin 1beta confers constitutive nuclear factor kappaB activity and chemoresistance in pancreatic carcinoma cell lines . Cancer Res , 62 : 910 – 916 .
   PubMed Web of Science ®Google Scholar
• Saijo , Y , Tanaka , M , Miki , M , Usui , K Suzuki , T . 2002 . Proinflammatory cytokine IL-1 beta promotes tumor growth of Lewis lung carcinoma by induction of angiogenic factors: in vivo analysis of tumor-stromal interaction . J Immunol , 169 : 469 – 475 .
   PubMed Web of Science ®Google Scholar
• Lewis , A M , Varghese , S , Xu , H and Alexander , H R . 2006 . Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment . J Transl Med , 4 : 48
   PubMed Web of Science ®Google Scholar
• Ogata , A , Chauhan , D , Teoh , G , Treon , S P Urashima , M . 1997 . IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade . J Immunol , 159 : 2212 – 2221 .
   PubMed Web of Science ®Google Scholar
• Ara , T , Song , L , Shimada , H , Keshelava , N Russell , H V . 2009 . Interleukin-6 in the bone marrow microenvironment promotes the growth and survival of neuroblastoma cells . Cancer Res , 69 : 329 – 337 .
   PubMed Web of Science ®Google Scholar
• Bollrath , J , Phesse , T J , von Burstin , V A , Putoczki , T Bennecke , M . 2009 . gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis . Cancer Cell , 15 : 91 – 102 .
   PubMed Web of Science ®Google Scholar
• Quintanilla-Martinez , L , Kremer , M , Specht , K , Calzada-Wack , J Nathrath , M . 2003 . Analysis of signal transducer and activator of transcription 3 (Stat 3) pathway in multiple myeloma: Stat 3 activation and cyclin D1 dysregulation are mutually exclusive events . Am J Pathol , 162 : 1449 – 1461 .
   PubMed Web of Science ®Google Scholar
• Niu , G , Bowman , T , Huang , M , Shivers , S Reintgen , D . 2002 . Roles of activated Src and Stat3 signaling in melanoma tumor cell growth . Oncogene , 21 : 7001 – 7010 .
   PubMed Web of Science ®Google Scholar
• Xu , Y X , Pindolia , K R , Janakiraman , N , Noth , C J Chapman , R A . 1997 . Curcumin, a compound with antiinflammatory and antioxidant properties, downregulates chemokine expression in bone marrow stromal cells . Exp Hematol , 25 : 413 – 422 .
   PubMed Web of Science ®Google Scholar
• Chan , M M . 1995 . Inhibition of tumor necrosis factor by curcumin, a phytochemical . Biochem Pharmacol , 49 : 1551 – 1556 .
   PubMed Web of Science ®Google Scholar
• Kang , J H , Kim , C S , Han , I S , Kawada , T and Yu , R . 2007 . Capsaicin, a spicy component of hot peppers, modulates adipokine gene expression and protein release from obese-mouse adipose tissues and isolated adipocytes, and suppresses the inflammatory responses of adipose tissue macrophages . FEBS Lett , 581 : 4389 – 4396 .
   PubMed Web of Science ®Google Scholar
• Jung , D H , Park , H J , Byun , H E , Park , Y M Kim , T W . 2010 . Diosgenin inhibits macrophage-derived inflammatory mediators through downregulation of CK2, JNK, NF-kappaB, and AP-1 activation . Int Immunopharmacol , 10 : 1047 – 1054 .
   PubMed Web of Science ®Google Scholar
• Cao , Y and Prescott , S M . 2002 . Many actions of cyclooxygenase-2 in cellular dynamics and in cancer . J Cell Physiol , 190 : 279 – 286 .
   PubMed Web of Science ®Google Scholar
• Sobolewski , C , Cerella , C , Dicato , M , Ghibelli , L and Diederich , M . 2010 . The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies . Int J Cell Biol , 2010 : 215158
   PubMedGoogle Scholar
• DuBois , R N , Shao , J , Tsujii , M , Sheng , H and Beauchamp , R D . 1996 . G1 delay in cells overexpressing prostaglandin endoperoxide synthase-2 . Cancer Res , 56 : 733 – 737 .
   PubMed Web of Science ®Google Scholar
• Takeda , H , Sonoshita , M , Oshima , H , Sugihara , K Chulada , P C . 2003 . Cooperation of cyclooxygenase 1 and cyclooxygenase 2 in intestinal polyposis . Cancer Res , 63 : 4872 – 4877 .
   PubMed Web of Science ®Google Scholar
• Einspahr , J G , Krouse , R S , Yochim , J M , Danenberg , P V Danenberg , K D . 2003 . Association between cyclooxygenase expression and colorectal adenoma characteristics . Cancer Res , 63 : 3891 – 3893 .
   PubMed Web of Science ®Google Scholar
• Half , E , Tang , X M , Gwyn , K , Sahin , A Wathen , K . 2002 . Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ . Cancer Res , 62 : 1676 – 1681 .
   PubMed Web of Science ®Google Scholar
• Kundu , N and Fulton , A M . 2002 . Selective cyclooxygenase (COX)-1 or COX-2 inhibitors control metastatic disease in a murine model of breast cancer . Cancer Res , 62 : 2343 – 2346 .
   PubMed Web of Science ®Google Scholar
• Wolff , H , Saukkonen , K , Anttila , S , Karjalainen , A Vainio , H . 1998 . Expression of cyclooxygenase-2 in human lung carcinoma . Cancer Res , 58 : 4997 – 5001 .
   PubMed Web of Science ®Google Scholar
• Pold , M , Zhu , L X , Sharma , S , Burdick , M D Lin , Y . 2004 . Cyclooxygenase-2-dependent expression of angiogenic CXC chemokines ENA-78/CXC Ligand (CXCL) 5 and interleukin-8/CXCL8 in human non-small cell lung cancer . Cancer Res , 64 : 1853 – 1860 .
   PubMed Web of Science ®Google Scholar
• Davenport , H W . 1965 . Damage to the gastric mucosa: effects of salicylates and stimulation . Gastroenterology , 49 : 189 – 196 .
   PubMed Web of Science ®Google Scholar
• Gottlieb , S . 2001 . COX 2 inhibitors may increase risk of heart attack . BMJ , 323 : 471
   PubMed Web of Science ®Google Scholar
• Huang , M T , Lysz , T , Ferraro , T , Abidi , T F Laskin , J D . 1991 . Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis . Cancer Res , 51 : 813 – 819 .
   PubMed Web of Science ®Google Scholar
• Ammon , H P , Safayhi , H , Mack , T and Sabieraj , J . 1993 . Mechanism of antiinflammatory actions of curcumine and boswellic acids . J Ethnopharmacol , 38 : 113 – 119 .
   PubMed Web of Science ®Google Scholar
• Zhang , F , Altorki , N K , Mestre , J R , Subbaramaiah , K and Dannenberg , A J . 1999 . Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells . Carcinogenesis , 20 : 445 – 451 .
   PubMed Web of Science ®Google Scholar
• Lee , Y S , Kwon , E J , Jin , D Q , Park , S H Kang , Y S . 2002 . Redox status-dependent regulation of cyclooxygenases mediates the capsaicin-induced apoptosis in human neuroblastoma cells . J Environ Pathol Toxicol Oncol , 21 : 113 – 120 .
   PubMedGoogle Scholar
• Kiuchi , F , Iwakami , S , Shibuya , M , Hanaoka , F and Sankawa , U . 1992 . Inhibition of prostaglandin and leukotriene biosynthesis by gingerols and diarylheptanoids . Chem Pharm Bull (Tokyo) , 40 : 387 – 391 .
   PubMed Web of Science ®Google Scholar
• Flynn , D L , Rafferty , M F and Boctor , A M . 1986 . Inhibition of 5-hydroxy-eicosatetraenoic acid (5-HETE) formation in intact human neutrophils by naturally occurring diarylheptanoids: inhibitory activities of curcuminoids and yakuchinones . Prostaglandins Leukot Med , 22 : 357 – 360 .
   PubMedGoogle Scholar
• Lee , Y Y , Yang , S F , Ho , W H , Lee , Y H and Hung , S L . 2007 . Eugenol modulates cyclooxygenase-2 expression through the activation of nuclear factor kappa B in human osteoblasts . J Endod , 33 : 1177 – 1182 .
   PubMed Web of Science ®Google Scholar
• Kim , S S , Oh , O J , Min , H Y , Park , E J Kim , Y . 2003 . Eugenol suppresses cyclooxygenase-2 expression in lipopolysaccharide-stimulated mouse macrophage RAW264.7 cells . Life Sci , 73 : 337 – 348 .
   PubMed Web of Science ®Google Scholar
• Hong , J , Bose , M , Ju , J , Ryu , J H Chen , X . 2004 . Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase . Carcinogenesis , 25 : 1671 – 1679 .
   PubMed Web of Science ®Google Scholar
• Marsik , P , Kokoska , L , Landa , P , Nepovim , A Soudek , P . 2005 . In vitro inhibitory effects of thymol and quinones of Nigella sativa seeds on cyclooxygenase-1- and -2-catalyzed prostaglandin E2 biosyntheses . Planta Med , 71 : 739 – 742 .
   PubMed Web of Science ®Google Scholar
• Chehl , N , Chipitsyna , G , Gong , Q , Yeo , C J and Arafat , H A . 2009 . Antiinflammatory effects of the Nigella sativa seed extract, thymoquinone, in pancreatic cancer cells . HPB (Oxford) , 11 : 373 – 381 .
   PubMed Web of Science ®Google Scholar
• Boado , R J , Pardridge , W M , Vinters , H V and Black , K L . 1992 . Differential expression of arachidonate 5-lipoxygenase transcripts in human brain tumors: evidence for the expression of a multitranscript family . Proc Natl Acad Sci USA , 89 : 9044 – 9048 .
   PubMed Web of Science ®Google Scholar
• Ye , Y N , Wu , W K , Shin , V Y , Bruce , I C Wong , B C . 2005 . Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke . Carcinogenesis , 26 : 827 – 834 .
   PubMed Web of Science ®Google Scholar
• Faronato , M , Muzzonigro , G , Milanese , G , Menna , C Bonfigli , A R . 2007 . Increased expression of 5-lipoxygenase is common in clear cell renal cell carcinoma . Histol Histopathol , 22 : 1109 – 1118 .
   PubMed Web of Science ®Google Scholar
• Jiang , W G , Douglas-Jones , A G and Mansel , R E . 2006 . Aberrant expression of 5-lipoxygenase-activating protein (5-LOXAP) has prognostic and survival significance in patients with breast cancer . Prostaglandins Leukot Essent Fatty Acids , 74 : 125 – 134 .
   PubMed Web of Science ®Google Scholar
• Hennig , R , Grippo , P , Ding , X Z , Rao , S M Buchler , M W . 2005 . 5-Lipoxygenase, a marker for early pancreatic intraepithelial neoplastic lesions . Cancer Res , 65 : 6011 – 6016 .
   PubMed Web of Science ®Google Scholar
• Lepage , C , Liagre , B , Cook-Moreau , J , Pinon , A and Beneytout , J L . 2010 . Cyclooxygenase-2 and 5-lipoxygenase pathways in diosgenin-induced apoptosis in HT-29 and HCT-116 colon cancer cells . Int J Oncol , 36 : 1183 – 1191 .
   PubMed Web of Science ®Google Scholar
• Adams , J . 2003 . The proteasome: structure, function, and role in the cell . Cancer Treat Rev , 29 ( Suppl 1 ) : 3 – 9 .
   PubMed Web of Science ®Google Scholar
• Glotzer , M , Murray , A W and Kirschner , M W . 1991 . Cyclin is degraded by the ubiquitin pathway . Nature , 349 : 132 – 138 .
   PubMed Web of Science ®Google Scholar
• Scheffner , M , Werness , B A , Huibregtse , J M , Levine , A J and Howley , P M . 1990 . The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 . Cell , 63 : 1129 – 1136 .
   PubMed Web of Science ®Google Scholar
• Li , B and Dou , Q P . 2000 . Bax degradation by the ubiquitin/proteasome-dependent pathway: involvement in tumor survival and progression . Proc Natl Acad Sci USA , 97 : 3850 – 3855 .
   PubMed Web of Science ®Google Scholar
• Pagano , M , Tam , S W , Theodoras , A M , Beer-Romero , P Del Sal , G . 1995 . Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27 . Science , 269 : 682 – 685 .
   PubMed Web of Science ®Google Scholar
• Chen , Z , Hagler , J , Palombella , V J , Melandri , F Scherer , D . 1995 . Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway . Genes Dev , 9 : 1586 – 1597 .
   PubMed Web of Science ®Google Scholar
• Drexler , H C . 1997 . Activation of the cell death program by inhibition of proteasome function . Proc Natl Acad Sci USA , 94 : 855 – 860 .
   PubMed Web of Science ®Google Scholar
• Orlowski , R Z . 1999 . The role of the ubiquitin-proteasome pathway in apoptosis . Cell Death Diff , 6 : 303 – 313 .
   PubMed Web of Science ®Google Scholar
• Adams , J . 2004 . The development of proteasome inhibitors as anticancer drugs . Cancer Cell , 5 : 417 – 421 .
   PubMed Web of Science ®Google Scholar
• Milacic , V , Banerjee , S , Landis-Piwowar , K R , Sarkar , F H Majumdar , A P . 2008 . Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo . Cancer Res , 68 : 7283 – 7292 .
   PubMed Web of Science ®Google Scholar
• Mori , A , Lehmann , S , O’Kelly , J , Kumagai , T Desmond , J C . 2006 . Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells . Cancer Res , 66 : 3222 – 3229 .
   PubMed Web of Science ®Google Scholar
• Maity , R , Sharma , J and Jana , N R . 2010 . Capsaicin induces apoptosis through ubiquitin-proteasome system dysfunction . J Cell Biochem , 109 : 933 – 942 .
   PubMed Web of Science ®Google Scholar
• Cecarini , V , Quassinti , L , Di Blasio , A , Bonfili , L Bramucci , M . 2010 . Effects of thymoquinone on isolated and cellular proteasomes . FEBS J , 277 : 2128 – 2141 .
   PubMed Web of Science ®Google Scholar
• Lust , S , Vanhoecke , B , Vang , M , Boelens , J and Vanm , H . 2009 . Xanthohumol activates the proapoptotic arm of the unfolded protein response in chronic lymphocytic leukemia . Anticancer Res , 29 : 3797 – 3805 .
   PubMed Web of Science ®Google Scholar
• Waddington , C H . 1942 . The epigenotype . Endeavour , 1 : 18 – 20 .
   Google Scholar
• Jones , P A and Baylin , S B . 2007 . The epigenomics of cancer . Cell , 128 : 683 – 692 .
   PubMed Web of Science ®Google Scholar
• Ellis , L , Atadja , P W and Johnstone , R W . 2009 . Epigenetics in cancer: targeting chromatin modifications . Mol Cancer Ther , 8 : 1409 – 1420 .
   PubMed Web of Science ®Google Scholar
• Esteller , M . 2007 . Cancer epigenomics: DNA methylomes and histone-modification maps . Nat Rev Genet , 8 : 286 – 298 .
   PubMed Web of Science ®Google Scholar
• Klose , R J and Bird , A P . 2006 . Genomic DNA methylation: the mark and its mediators . Trends Biochem Sci , 31 : 89 – 97 .
   PubMed Web of Science ®Google Scholar
• Kouzarides , T . 2007 . Chromatin modifications and their function . Cell , 128 : 693 – 705 .
   PubMed Web of Science ®Google Scholar
• Reuter , S , Gupta , S C , Park , B , Goel , A and Aggarwal , B B . 2011 . Epigenetic changes induced by curcumin and other natural compounds . Genes Nutr ,
   Web of Science ®Google Scholar
• Liu , S , Shen , T , Huynh , L , Klisovic , M I Rush , L J . 2005 . Interplay of RUNX1/MTG8 and DNA methyltransferase 1 in acute myeloid leukemia . Cancer Res , 65 : 1277 – 1284 .
   PubMed Web of Science ®Google Scholar
• Balasubramanyam , K , Varier , R A , Altaf , M , Swaminathan , V Siddappa , N B . 2004 . Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription . J Biol Chem , 279 : 51163 – 51171 .
   PubMed Web of Science ®Google Scholar
• Pollack , B P , Sapkota , B and Boss , J M . 2009 . Ultraviolet radiation-induced transcription is associated with gene-specific histone acetylation . Photochem Photobiol , 85 : 652 – 662 .
   PubMed Web of Science ®Google Scholar
• Chen , I H , Lu , M C , Du , Y C , Yen , M H Wu , C C . 2009 . Cytotoxic triterpenoids from the stems of Microtropis japonica . J Nat Prod , 72 : 1231 – 1236 .
   PubMed Web of Science ®Google Scholar
• Sharma , R A , McLelland , H R , Hill , K A , Ireson , C R Euden , S A . 2001 . Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer . Clin Cancer Res , 7 : 1894 – 1900 .
   PubMed Web of Science ®Google Scholar
• Sharma , R A , Euden , S A , Platton , S L , Cooke , D N Shafayat , A . 2004 . Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance . Clin Cancer Res , 10 : 6847 – 6854 .
   PubMed Web of Science ®Google Scholar
• Garcea , G , Berry , D P , Jones , D J , Singh , R Dennison , A R . 2005 . Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences . Cancer Epidemiol Biomarkers Prev , 14 : 120 – 125 .
   PubMed Web of Science ®Google Scholar
• Kuttan , R , Sudheeran , P C and Josph , C D . 1987 . Turmeric and curcumin as topical agents in cancer therapy . Tumori , 73 : 29 – 31 .
   PubMed Web of Science ®Google Scholar
• Cruz-Correa , M , Shoskes , D A , Sanchez , P , Zhao , R Hylind , L M . 2006 . Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis . Clin Gastroenterol Hepatol , 4 : 1035 – 1038 .
   PubMed Web of Science ®Google Scholar
• Bayet-Robert , M , Kwiatkowski , F , Leheurteur , M , Gachon , F Planchat , E . 2010 . Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer . Cancer Biol Ther , 9 : 8 – 14 .
   PubMed Web of Science ®Google Scholar
• Vadhan , V S , Weber , D , Giralt , S , Alexanian , R Thomas , S . 2007 . “ Curcumin downregulates NF-kappaB and related genes in patients with multiple myeloma: results of a phase1/2 study ” . American Society of Hematology .
   Google Scholar
• Dhillon , N , Aggarwal , B B , Newman , R A , Wolff , R A Kunnumakkara , A B . 2008 . Phase II trial of curcumin in patients with advanced pancreatic cancer . Clin Cancer Res , 14 : 4491 – 4499 .
   PubMed Web of Science ®Google Scholar
• Kanai , M , Yoshimura , K , Asada , M , Imaizumi , A Suzuki , C . 2011 . A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer . Cancer Chemother Pharmacol , 68 : 157 – 164 .
   PubMed Web of Science ®Google Scholar
• Epelbaum , R , Schaffer , M , Vizel , B , Badmaev , V and Bar-Sela , G . 2010 . Curcumin and gemcitabine in patients with advanced pancreatic cancer . Nutr Cancer , 62 : 1137 – 1141 .
   PubMed Web of Science ®Google Scholar
• Cheng , A L , Hsu , C H , Lin , J K , Hsu , M M Ho , Y F . 2001 . Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or premalignant lesions . Anticancer Res , 21 : 2895 – 2900 .
   PubMed Web of Science ®Google Scholar
• Rai , B , Kaur , J , Jacobs , R and Singh , J . 2010 . Possible action mechanism for curcumin in pre-cancerous lesions based on serum and salivary markers of oxidative stress . J Oral Sci , 52 : 251 – 256 .
   PubMedGoogle Scholar
• Ide , H , Tokiwa , S , Sakamaki , K , Nishio , K Isotani , S . 2010 . Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate-specific antigen . Prostate , 70 : 1127 – 1133 .
   PubMed Web of Science ®Google Scholar
• Pillai , A K , Sharma , K K , Gupta , Y K and Bakhshi , S . 2011 . Anti-emetic effect of ginger powder versus placebo as an add-on therapy in children and young adults receiving high emetogenic chemotherapy . Pediatr Blood Cancer , 56 : 234 – 238 .
   PubMed Web of Science ®Google Scholar
• Zick , S M , Ruffin , M T , Lee , J , Normolle , D P Siden , R . 2009 . Phase II trial of encapsulated ginger as a treatment for chemotherapy-induced nausea and vomiting . Support Care Cancer , 17 : 563 – 572 .
   PubMed Web of Science ®Google Scholar
• Levine , M E , Gillis , M G , Koch , S Y , Voss , A C Stern , R M . 2008 . Protein and ginger for the treatment of chemotherapy-induced delayed nausea . J Altern Complement Med , 14 : 545 – 551 .
   PubMed Web of Science ®Google Scholar
• Ellison , N , Loprinzi , C L , Kugler , J , Hatfield , A K Miser , A . 1997 . Phase III placebo-controlled trial of capsaicin cream in the management of surgical neuropathic pain in cancer patients . J Clin Oncol , 15 : 2974 – 2980 .
   PubMed Web of Science ®Google Scholar
• Berger , A , Henderson , M , Nadoolman , W , Duffy , V Cooper , D . 1995 . Oral capsaicin provides temporary relief for oral mucositis pain secondary to chemotherapy/radiation therapy . J Pain Symptom Manage , 10 : 243 – 248 .
   PubMed Web of Science ®Google Scholar
• Lam , S , MacAulay , C , Le Riche , J C , Dyachkova , Y Coldman , A . 2002 . A randomized phase IIb trial of anethole dithiolethione in smokers with bronchial dysplasia . J Natl Cancer Inst , 94 : 1001 – 1009 .
   PubMed Web of Science ®Google Scholar
• Kunnumakkara , A B , Anand , P and Aggarwal , B B . 2008 . Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins . Cancer Lett , 269 : 199 – 225 .
   PubMed Web of Science ®Google Scholar
• Garcea , G , Jones , D J , Singh , R , Dennison , A R Farmer , P B . 2004 . Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration . Br J Cancer , 90 : 1011 – 1015 .
   PubMed Web of Science ®Google Scholar
• Ireson , C , Orr , S , Jones , D J , Verschoyle , R Lim , C K . 2001 . Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production . Cancer Res , 61 : 1058 – 1064 .
   PubMed Web of Science ®Google Scholar
• Rafailov , S , Cammack , S , Stone , B A and Katz , A E . 2007 . The role of Zyflamend, an herbal anti-inflammatory, as a potential chemopreventive agent against prostate cancer: a case report . Integr Cancer Ther , 6 : 74 – 76 .
   PubMed Web of Science ®Google Scholar
• Hickok , J T , Roscoe , J A , Morrow , G R and Ryan , J L . 2007 . A Phase II/III Randomized, placebo-controlled, double-blind clinical trial of ginger (zingiber officinale) for nausea caused by chemotherapy for cancer: a currently accruing URCC CCOP cancer control study . Support Cancer Ther , 4 : 247 – 250 .
   PubMedGoogle Scholar
• Manusirivithaya , S , Sripramote , M , Tangjitgamol , S , Sheanakul , C Leelahakorn , S . 2004 . Antiemetic effect of ginger in gynecologic oncology patients receiving cisplatin . Int J Gynecol Cancer , 14 : 1063 – 1069 .
   PubMed Web of Science ®Google Scholar
• Pyun , B J , Choi , S , Lee , Y , Kim , T W Min , J K . 2008 . Capsiate, a nonpungent capsaicin-like compound, inhibits angiogenesis and vascular permeability via a direct inhibition of Src kinase activity . Cancer Res , 68 : 227 – 235 .
   PubMed Web of Science ®Google Scholar
• Liddle , M , Hull , C , Liu , C and Powell , D . 2006 . Contact urticaria from curcumin . Dermatitis , 17 : 196 – 197 .
   PubMed Web of Science ®Google Scholar
• Futrell , J M and Rietschel , R L . 1993 . Spice allergy evaluated by results of patch tests . Cutis , 52 : 288 – 290 .
   PubMed Web of Science ®Google Scholar
• Lopez-Carrillo , L , Hernandez Avila , M and Dubrow , R . 1994 . Chili pepper consumption and gastric cancer in Mexico: a case-control study . Am J Epidemiol , 139 : 263 – 271 .
   PubMed Web of Science ®Google Scholar
• Surh , Y J and Lee , S S . 1996 . Capsaicin in hot chili pepper: carcinogen, co-carcinogen or anticarcinogen? . Food Chem Toxicol , 34 : 313 – 316 .
   PubMed Web of Science ®Google Scholar